Oral vaccination of tilapia against Streptococcus agalactiae using Bacillus subtilis spores expressing Sip
文献类型:期刊论文
作者 | Yao, Yuan-Yuan1,4; Chen, Dan-Dan1; Cui, Zheng-Wei1,4; Zhang, Xiang-Yang1,4; Zhou, Yuan-Yuan1,4; Guo, Xia5; Li, Ai-Hua1,6; Zhang, Yong-An1,2,3 |
刊名 | FISH & SHELLFISH IMMUNOLOGY
![]() |
出版日期 | 2019-03-01 |
卷号 | 86页码:999-1008 |
关键词 | Oreochromis niloticus Bacterial infection Vaccine Bacillus Surface display |
ISSN号 | 1050-4648 |
DOI | 10.1016/j.fsi.2018.12.060 |
英文摘要 | Streptococcus agalactiae infections are becoming an increasing problem in aquaculture because of significant morbidity and mortality, which restricts the healthy development of tilapia aquaculture. To seek safe and effective prevention measures, a Bacillus subtilis GC5 surface displayed vaccine was prepared and applied orally in tilapia. The study first showed that recombinant spores can engraft in the tilapia intestine. Then, the effect of protection and the immune responses were evaluated. The results of ELISA showed that Sip-specific antibody in the sera of GC5-Sip-immunized fish can be detected after the first oral administration when compared to the phosphate buffer saline (PBS) control group, and the levels of specific IgM gradually strengthened with boosting, so does the specific antibody against bacteria, proving that humoral immunity was induced. Quantitative real-time PCR (qRT-PCR) results showed that the immune-related gene expression of the gut and spleen exhibited a different rising trend in the GC5-Sip group, revealing that innate immune response and local as well as systemic cellular immunity were induced. The outcome of fish immunized with GC5-Sip spores provided a relative percent survival (RPS) of 41.7% against S. agalactiae and GC5 group had an RPS of 24.2%, indicating that GC5-Sip was safe and effective in protecting tilapia against bacterial infection. Our study demonstrated that the oral administration of B. subtilis spores expressing Sip could cause an effective immune response and offer good resistance to bacterial infection. Our work may lead to the development of new ideas for immunoprophylaxis against S. agalactiae infection. |
资助项目 | State Key Laboratory of Freshwater Ecology and Biotechnology[2016FBZ04] |
WOS研究方向 | Fisheries ; Immunology ; Marine & Freshwater Biology ; Veterinary Sciences |
语种 | 英语 |
WOS记录号 | WOS:000459528400110 |
出版者 | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD |
源URL | [http://202.127.146.157/handle/2RYDP1HH/6827] ![]() |
专题 | 中国科学院武汉植物园 |
通讯作者 | Li, Ai-Hua; Zhang, Yong-An |
作者单位 | 1.Chinese Acad Sci, Inst Hydrobiol, Wuhan, Hubei, Peoples R China 2.Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China 3.Huazhong Agr Univ, Coll Fisheries, State Key Lab Aquaculture Microbiol, Wuhan, Hubei, Peoples R China 4.Univ Chinese Acad Sci, Beijing, Peoples R China 5.Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Wuhan, Hubei, Peoples R China 6.Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan, Hubei, Peoples R China |
推荐引用方式 GB/T 7714 | Yao, Yuan-Yuan,Chen, Dan-Dan,Cui, Zheng-Wei,et al. Oral vaccination of tilapia against Streptococcus agalactiae using Bacillus subtilis spores expressing Sip[J]. FISH & SHELLFISH IMMUNOLOGY,2019,86:999-1008. |
APA | Yao, Yuan-Yuan.,Chen, Dan-Dan.,Cui, Zheng-Wei.,Zhang, Xiang-Yang.,Zhou, Yuan-Yuan.,...&Zhang, Yong-An.(2019).Oral vaccination of tilapia against Streptococcus agalactiae using Bacillus subtilis spores expressing Sip.FISH & SHELLFISH IMMUNOLOGY,86,999-1008. |
MLA | Yao, Yuan-Yuan,et al."Oral vaccination of tilapia against Streptococcus agalactiae using Bacillus subtilis spores expressing Sip".FISH & SHELLFISH IMMUNOLOGY 86(2019):999-1008. |
入库方式: OAI收割
来源:武汉植物园
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。